moroxybrate

Moroxybrate is a drug synthesized by the chemical reaction of clofibric acid with moroxydine, which is a biguanide with minimal effect on carbohydrate metabolism. The resulting compound has pharmacological effects at least as strong as clofibrate or moroxydine alone. It is characterized primarily as an antithrombotic agent, although published evidence on its approved clinical use, precise mechanism of action, or regulatory status is sparse. Its unique structure may combine hypolipidemic and antiviral/biguanide properties, but clinical indications, if any, are not well-documented in current mainstream pharmaceutical databases[3][7][9].